Latest DEF 14A proxy statements

Electronic Arts' Board accepts an offer to take the company private, citing compelling value for stockholders and a longer-term investment horizon.

Electronic Arts announced its acquisition by a consortium including PIF, Silver Lake, and Affinity Partners for $210 per share in cash, valuing the company at $55 billion.

Healthcare AI Acquisition Corp. has postponed its Extraordinary General Meeting to October 10, 2025, and proposes to extend its business combination deadline from March 14, 2026, to October 14, 2026.

La Rosa Holdings Corp. has secured stockholder approval to increase its equity purchase facility with SZOP Opportunities I LLC from $150 million to $1.0 billion, enabling the issuance of additional common shares.

Picard Medical, Inc. will hold a special meeting on October 10, 2025, to seek stockholder approval for an amendment to its 2021 Equity Incentive Plan, increasing available shares to 18 million and including warrants as award types.

American Rebel Holdings, Inc. informs stockholders of approved private placements and a real estate acquisition, involving significant debt and equity issuances.

CytoDyn Inc. announces its 2025 Annual Meeting of Stockholders to vote on director elections, auditor ratification, executive compensation, and a significant increase in authorized common stock.

Actelis Networks, Inc. is seeking stockholder approval for warrant issuances and a reverse stock split to comply with Nasdaq listing rules and enhance investor appeal.

Direct Digital Holdings, Inc. calls a Special Meeting to vote on increasing authorized Class A Common Stock to 760 million shares and approving the issuance of up to 50 million shares under an equity line of credit.

Elite Health Systems seeks stockholder approval for a special meeting to vote on key proposals including a share increase, equity incentive plan, and acquisition of Physician Support Systems, Inc.

Genmab A/S announced its intent to acquire Merus N.V. for $97.00 per share in an all-cash transaction valued at approximately $8.0 billion, aiming to expand its late-stage oncology pipeline.

Beyond Meat, Inc. has commenced an exchange offer for its 0% Convertible Senior Notes due 2027, aiming to reduce over $800 million in debt and extend maturity through new 7.00% convertible notes and common stock.

GameSquare Holdings, Inc. reminds shareholders to vote by October 6, 2025, on proposals for its upcoming annual meeting, including a technical statutory merger.

Electronic Arts Inc. has agreed to be acquired by an investor consortium for $210 per share in cash, valuing the company at approximately $55 billion.

Dayforce, Inc. stockholders are invited to a special meeting on November 12, 2025, to vote on a $70.00 per share all-cash acquisition by affiliates of Thoma Bravo, valuing the company at approximately $12.3 billion.

Two Seas Capital LP, a major shareholder, is actively soliciting votes AGAINST Core Scientific's proposed acquisition by CoreWeave, citing a flawed process, deficient structure, and inadequate valuation.

Dogwood Therapeutics obtained an exclusive, royalty-free global license for Serpin Pharma's SP16, a promising drug for chemotherapy-induced peripheral neuropathy, with its Phase 1b study fully funded by the National Cancer Institute.

Comscore announces a pivotal recapitalization transaction with its preferred stockholders, reducing senior capital and eliminating preferred dividend obligations to enhance long-term growth and stockholder alignment.

Trailblazer Merger Corporation I has updated its proxy statement, increasing the monthly deposit required for business combination extensions and adjourning its annual meeting.

Rent the Runway, Inc. is seeking stockholder approval for a comprehensive recapitalization plan to significantly reduce existing debt, improve interest rates, and extend maturities, crucial for avoiding potential bankruptcy.

Vivos Therapeutics, Inc. announced its 2025 Annual Meeting of Stockholders to be held virtually on November 4, 2025, seeking approval for director elections, an increased equity incentive plan, and auditor ratification.

Core Scientific's board unanimously recommends an all-stock merger with AI hyperscaler CoreWeave, offering stockholders a 27.2% premium and a stake in a rapidly growing AI infrastructure leader.

CoreCard Corporation will merge with Euronet Worldwide, Inc.'s subsidiary, becoming a wholly-owned entity in an all-stock transaction valued at an implied $30.00 per share under certain conditions.

Oracle Corporation announces its upcoming Annual Meeting of Stockholders on November 18, 2025, to vote on director elections, executive compensation, and auditor ratification.

Tilray Brands, Inc. has filed definitive additional proxy soliciting materials with the SEC.

Datavault AI Inc. announced that its majority stockholders approved the issuance of 5 million common shares to certain purchasers to comply with Nasdaq listing rules and in exchange for waivers on prior securities agreement terms.

Tesla, Inc. sent an internal communication to employees on September 26, 2025, encouraging them to vote in the upcoming 2025 annual meeting and review the Definitive Proxy Statement.

Invesco QQQ Trust is seeking shareholder approval to transition to a more flexible, open-ended ETF structure, promising lower costs and enhanced transparency.

Ethan Allen Interiors Inc. announced its 2025 Annual Meeting of Stockholders to be held virtually on November 5, 2025, to vote on director elections, executive compensation, and auditor ratification.

Coty Inc. has filed definitive additional materials related to its proxy statement under Schedule 14A.